Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Shiveena Bhatia, Ritchu Babbar, Mehrukh Zehravi, Balbir Singh, Parteek Chandel, Mohammad Mehedi Hasan, Rashmi Arora, Naresh S. Gill, Rakesh K. Sindhu, Zubair Ahmad, Farhat S. Khan & Md. Habibur Rahman. (2023) Angiogenic footprints in diabetic retinopathy: opportunities for drug development. Biotechnology and Genetic Engineering Reviews 39:1, pages 118-142.
Read now
Read now
Anna Bong, Michael J Doughty, Norman F Button & David C Mansfield. (2016) On the relationship between visual acuity and central retinal (macular) thickness after interventions for macular oedema in diabetics: a review. Clinical and Experimental Optometry 99:6, pages 491-497.
Read now
Read now
Laurence S Lim, Wei Yan Ng, Ranjana Mathur, Doric Wong, Edmund YM Wong, Ian Yeo, Chui Ming Gemmy Cheung, Shu Yen Lee, Tien Yin Wong, Thanos D Papakostas & Leo A Kim. (2015) Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab. Clinical Ophthalmology 9, pages 1715-1718.
Read now
Read now
Seung Hyen Lee, Jaeyoung Kim, Hyewon Chung & Hyung Chan Kim. (2014) Changes of Choroidal Thickness After Treatment for Diabetic Retinopathy. Current Eye Research 39:7, pages 736-744.
Read now
Read now
Hye-Eun JOO, Hyo-Jung LEE, Eun Jung SOHN, Min-Ho LEE, Hyun-Suk KO, Soo-Jin JEONG, Hyo-Jeong LEE & Sung-Hoon KIM. (2013) Anti-Diabetic Potential of the Essential Oil of Pinus koraiensis Leaves toward Streptozotocin-Treated Mice and HIT-T15 Pancreatic β Cells. Bioscience, Biotechnology, and Biochemistry 77:10, pages 1997-2001.
Read now
Read now
Ik Soo Byon, Hye Shin Jeon, Hyun Woong Kim, Sang Joon Lee, Ji Eun Lee & Boo Sup Oum. (2013) The Effect of a Systemic Angiotensin Receptor Blocker on Vascular Endothelial Growth Factor in the Vitreous of Patients with Proliferative Diabetic Retinopathy. Current Eye Research 38:7, pages 774-780.
Read now
Read now
Jayamanti Pandit & Yasmin Sultana. (2012) Vascular damage of retina in diabetic retinopathy and its treatment. Expert Review of Ophthalmology 7:1, pages 73-86.
Read now
Read now
Ghulam Mohammad & Renu A Kowluru. (2011) The role of Raf-1 kinase in diabetic retinopathy. Expert Opinion on Therapeutic Targets 15:4, pages 357-364.
Read now
Read now
Articles from other publishers (54)
V. Yu. Evgrafov & G. R. Kudasheva. (2022) The Use of Vascular Endothelial Growth Factor Inhibitors in Patients with Proliferative Diabetic Retinopathy. Ophthalmology in Russia 19:2, pages 405-412.
Crossref
Crossref
Wuyue Zhang, Jinsong Geng & Aimin Sang. (2022) Effectiveness of Panretinal Photocoagulation Plus Intravitreal Anti-VEGF Treatment Against PRP Alone for Diabetic Retinopathy: A Systematic Review With Meta-Analysis. Frontiers in Endocrinology 13.
Crossref
Crossref
Monta Ustinova, Raitis Peculis, Raimonds Rescenko, Vita Rovite, Linda Zaharenko, Ilze Elbere, Laila Silamikele, Ilze Konrade, Jelizaveta Sokolovska, Valdis Pirags & Janis Klovins. (2021) Novel susceptibility loci identified in a genome-wide association study of type 2 diabetes complications in population of Latvia. BMC Medical Genomics 14:1.
Crossref
Crossref
Cuong HoangAnh Kim NguyenThai Q. NguyenWilliam FangBo HanBa X. HoangHau D. Tran. (2021) Application of Dimethyl Sulfoxide as a Therapeutic Agent and Drug Vehicle for Eye Diseases. Journal of Ocular Pharmacology and Therapeutics 37:8, pages 441-451.
Crossref
Crossref
Rute S. Araújo & Gabriela A. Silva. (2020) PlGF silencing combined with PEDF overexpression: Modeling RPE secretion as potential therapy for retinal neovascularization. Molecular Biology Reports 47:6, pages 4413-4425.
Crossref
Crossref
Jing Gao, Maimaiti Ailifeire, Chenfei Wang, Li Luo, Jie Zhang, Li Yuan, Li Zhang, Xiaolan Li & Minzhe Wang. (2020) miR-320/VEGFA axis affects high glucose-induced metabolic memory during human umbilical vein endothelial cell dysfunction in diabetes pathology. Microvascular Research 127, pages 103913.
Crossref
Crossref
Gaku Terauchi, Kei Shinoda, Hiroyuki Sakai, Makoto Kawashima, Celso Soiti Matsumoto, Atsushi Mizota & Yozo Miyake. (2019) Retinal function determined by flicker ERGs before and soon after intravitreal injection of anti-VEGF agents. BMC Ophthalmology 19:1.
Crossref
Crossref
Jo Ann Buczek-Thomas, Celeste B. Rich & Matthew A. Nugent. (2019) Hypoxia Induced Heparan Sulfate Primes the Extracellular Matrix for Endothelial Cell Recruitment by Facilitating VEGF-Fibronectin Interactions. International Journal of Molecular Sciences 20:20, pages 5065.
Crossref
Crossref
Dumitrita Ruginǎ, Raluca Ghiman, Monica Focșan, Flaviu Tăbăran, Florina Copaciu, Maria Suciu, Adela Pintea & Simion Aștilean. (2019) Resveratrol-delivery vehicle with anti-VEGF activity carried to human retinal pigmented epithelial cells exposed to high-glucose induced conditions. Colloids and Surfaces B: Biointerfaces 181, pages 66-75.
Crossref
Crossref
Yuanjun Li & Yedi Zhou. (2019) Interleukin-17: The Role for Pathological Angiogenesis in Ocular Neovascular Diseases. The Tohoku Journal of Experimental Medicine 247:2, pages 87-98.
Crossref
Crossref
Ailing Sui, Yisheng Zhong, Anna M. Demetriades, Qing Lu, Yujuan Cai, Yushuo Gao, Yanji Zhu, Xi Shen & Bing Xie. (2018) Inhibition of integrin α5β1 ameliorates VEGF-induced retinal neovascularization and leakage by suppressing NLRP3 inflammasome signaling in a mouse model. Graefe's Archive for Clinical and Experimental Ophthalmology 256:5, pages 951-961.
Crossref
Crossref
Shruti Chandra, Jay Sheth, Giridhar Anantharaman & Mahesh Gopalakrishnan. (2018) Ranibizumab-induced retinal reperfusion and regression of neovascularization in diabetic retinopathy: An angiographic illustration. American Journal of Ophthalmology Case Reports 9, pages 41-44.
Crossref
Crossref
Aditya Kelkar, Jai Kelkar, Hetal Mehta & Winfried Amoaku. (2018) Cataract surgery in diabetes mellitus: A systematic review. Indian Journal of Ophthalmology 66:10, pages 1401.
Crossref
Crossref
Sayon Roy, Timothy S. Kern, Brian Song & Caren Stuebe. (2017) Mechanistic Insights into Pathological Changes in the Diabetic Retina. The American Journal of Pathology 187:1, pages 9-19.
Crossref
Crossref
Ramak Roohipoor, Elaheh Sharifian, Fariba Ghassemi, Mohammad Riazi-Esfahani, Reza Karkhaneh, Masoud Aghsaei Fard, Mohammad Zarei, Bobeck S. Modjtahedi & Sasan Moghimi. (2016) CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB. Retina 36:10, pages 1997-2005.
Crossref
Crossref
. 2016. The Glycemic Index. The Glycemic Index
219
271
.
Nicolette Binz, Elizabeth P. Rakoczy, Ireni S. Ali Rahman, Nermina N. Vagaja & Chooi-May Lai. (2016) Biomarkers for Diabetic Retinopathy – Could Endothelin 2 Be Part of the Answer?. PLOS ONE 11:8, pages e0160442.
Crossref
Crossref
Qader Motarjemizadeh, Naser Samadi Aidenloo & Siamak Sepehri. (2015) A comparative study of different concentrations of topical bevacizumab on the recurrence rate of excised primary pterygium: a short-term follow-up study. International Ophthalmology 36:1, pages 63-71.
Crossref
Crossref
Bibhudatta Mishra, Anand Swaroop & RajP Kandpal. (2016) Genetic components in diabetic retinopathy. Indian Journal of Ophthalmology 64:1, pages 55.
Crossref
Crossref
Ryan Lee, Tien Y. Wong & Charumathi Sabanayagam. (2015) Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye and Vision 2:1.
Crossref
Crossref
Cammi N. Valdez, Joseph F. Arboleda-Velasquez, Dhanesh S. Amarnani, Leo A. Kim & Patricia A. D'Amore. (2014) Retinal Microangiopathy in a Mouse Model of Inducible Mural Cell Loss. The American Journal of Pathology 184:10, pages 2618-2626.
Crossref
Crossref
Sami Alkayyali & Valeriya Lyssenko. (2014) Genetics of diabetes complications. Mammalian Genome 25:9-10, pages 384-400.
Crossref
Crossref
Dawei Sun, Shintaro Nakao, Fang Xie, Souska Zandi, Abouzar Bagheri, Mozhgan Rezaei Kanavi, Shahram Samiei, Zahra‐Soheila Soheili, Sonja Frimmel, Zhongyu Zhang, Zsolt Ablonczy, Hamid Ahmadieh & Ali Hafezi‐Moghadam. (2014) Molecular imaging reveals elevated VEGFR‐2 expression in retinal capillaries in diabetes: a novel biomarker for early diagnosis. The FASEB Journal 28:9, pages 3942-3951.
Crossref
Crossref
P Osaadon, X J Fagan, T Lifshitz & J Levy. (2014) A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye 28:5, pages 510-520.
Crossref
Crossref
Timothy S. Kern. (2014) Interrelationships between the Retinal Neuroglia and Vasculature in Diabetes. Diabetes & Metabolism Journal 38:3, pages 163.
Crossref
Crossref
Joseph F. Arboleda-Velasquez & Patricia A. D’Amore. 2014. Cellular and Molecular Pathobiology of Cardiovascular Disease. Cellular and Molecular Pathobiology of Cardiovascular Disease
181
196
.
Patricio A Pacheco, Adam Mapani & Ratimir Lazic. (2013) The use of vascular endothelial growth factor inhibitors (anti-VEGFs) for the treatment of diabetic retinopathy. International Journal of Ophthalmic Practice 4:3, pages 104-108.
Crossref
Crossref
Shinsuke Nakamura, Haruka Takizawa, Masamitsu Shimazawa, Yuhei Hashimoto, Sou Sugitani, Kazuhiro Tsuruma & Hideaki Hara. (2013) Mild Endoplasmic Reticulum Stress Promotes Retinal Neovascularization via Induction of BiP/GRP78. PLoS ONE 8:3, pages e60517.
Crossref
Crossref
Nuno M. Beirão, Vasco Miranda, Idalina Beirão, Paulo P. Costa & Paulo Torres. (2013) THE USE OF INTRAVITREAL RANIBIZUMAB TO TREAT NEOVASCULAR GLAUCOMA BECAUSE OF RETINAL AMYLOID ANGIOPATHY IN FAMILIAL AMYLOIDOSIS TRANSTHYRETIN V30M RELATED. Retinal Cases & Brief Reports 7:1, pages 114-116.
Crossref
Crossref
Umesh C.S. Yadav, Satish K. Srivastava & Kota V. Ramana. (2012) Prevention of VEGF-induced growth and tube formation in human retinal endothelial cells by aldose reductase inhibition. Journal of Diabetes and its Complications 26:5, pages 369-377.
Crossref
Crossref
Stephen S. Feman, Jiajing Chen & Thomas E. Burroughs. (2012) Change in Diabetic Panretinal Photocoagulation Incidence. Ophthalmic Surgery, Lasers and Imaging Retina 43:4, pages 270-274.
Crossref
Crossref
Scott D. Fitzpatrick, M.A. Jafar Mazumder, Benjamin Muirhead & Heather Sheardown. (2012) Development of injectable, resorbable drug-releasing copolymer scaffolds for minimally invasive sustained ophthalmic therapeutics. Acta Biomaterialia 8:7, pages 2517-2528.
Crossref
Crossref
M. A. Jafar Mazumder, Scott D. Fitzpatrick, Ben Muirhead & Heather Sheardown. (2012) Cell‐adhesive thermogelling PNIPAAm/hyaluronic acid cell delivery hydrogels for potential application as minimally invasive retinal therapeutics. Journal of Biomedical Materials Research Part A 100A:7, pages 1877-1887.
Crossref
Crossref
André Messias, José Afonso Ramos Filho, Katharina Messias, Felipe P. P. Almeida, Rogério A. Costa, Ingrid U. Scott, Florian Gekeler & Rodrigo Jorge. (2012) Electroretinographic findings associated with panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab treatment for high-risk proliferative diabetic retinopathy. Documenta Ophthalmologica 124:3, pages 225-236.
Crossref
Crossref
Gemma Tremolada, Claudia Del Turco, Rosangela Lattanzio, Silvia Maestroni, Anna Maestroni, Francesco Bandello & Gianpaolo Zerbini. (2012) The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment. Experimental Diabetes Research 2012, pages 1-8.
Crossref
Crossref
Takeshi Yoshida, Junsong Gong, Zhenhua Xu, Yanhong Wei & Elia J. Duh. (2012) Inhibition of pathological retinal angiogenesis by the integrin ?v?3 antagonist tetraiodothyroacetic acid (tetrac). Experimental Eye Research 94:1, pages 41-48.
Crossref
Crossref
David A. Quillen & Thomas W. Gardner. 2012. Ophthalmic Surgery: Principles and Practice. Ophthalmic Surgery: Principles and Practice
528
535
.
Timothy S. Kern. 2012. Visual Dysfunction in Diabetes. Visual Dysfunction in Diabetes
143
155
.
Andreas Stahl, Ann Hellstrom, Chatarina Lofqvist & Lois Smith. 2012. Visual Dysfunction in Diabetes. Visual Dysfunction in Diabetes
233
244
.
Aysha Salam, Raeba Mathew & Sobha Sivaprasad. (2011) Treatment of proliferative diabetic retinopathy with anti-VEGF agents. Acta Ophthalmologica 89:5, pages 405-411.
Crossref
Crossref
Phillip Kantharidis, Bo Wang, Rosemarie M. Carew & Hui Yao Lan. (2011) Diabetes Complications: The MicroRNA Perspective. Diabetes 60:7, pages 1832-1837.
Crossref
Crossref
Ga?lle Pell?Nasim Shweke, Jean-Paul Duong Van Huyen, Le?la Tricot, Sadika Hessa?ne, V?ronique Fr?meaux-Bacchi, Christian Hiesse & Michel Delahousse. (2011) Systemic and Kidney Toxicity of Intraocular Administration of Vascular Endothelial Growth Factor Inhibitors. American Journal of Kidney Diseases 57:5, pages 756-759.
Crossref
Crossref
Zheng Sun, Jin Liu, Xiaohui Zeng, Jieqiong Huangfu, Yue Jiang, Mingfu Wang & Feng Chen. (2011) Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells. Food & Function 2:5, pages 251.
Crossref
Crossref
Chung-Jung Chiu & Allen Taylor. (2011) Dietary hyperglycemia, glycemic index and metabolic retinal diseases. Progress in Retinal and Eye Research 30:1, pages 18-53.
Crossref
Crossref
Soo-Jin Jeong, Wonil Koh, Eun-Ok Lee, Hyo-Jung Lee, Hyo-Jeong Lee, Hyunsu Bae, Junxuan Lü & Sung-Hoon Kim. (2011) Antiangiogenic phytochemicals and medicinal herbs. Phytotherapy Research 25:1, pages 1-10.
Crossref
Crossref
Alessandro Doria. (2010) Genetics of Diabetes Complications. Current Diabetes Reports 10:6, pages 467-475.
Crossref
Crossref
Ying Yang, Bradley T Andresen, Ke Yang, Ying Zhang, Xiaojin Li, Xianli Li & Hui Wang. (2010) Association of vascular endothelial growth factor −634C/G polymorphism and diabetic retinopathy in type 2 diabetic Han Chinese. Experimental Biology and Medicine 235:10, pages 1204-1211.
Crossref
Crossref
Andreas Stahl, Armin Buchwald, Gottfried Martin, Bernd Junker, Jing Chen, Lutz L Hansen, Hansjurgen T Agostini, Lois E H Smith & Nicolas Feltgen. (2010) VITREAL LEVELS OF ERYTHROPOIETIN ARE INCREASED IN PATIENTS WITH RETINAL VEIN OCCLUSION AND CORRELATE WITH VITREAL VEGF AND THE EXTENT OF MACULAR EDEMA. Retina 30:9, pages 1524-1529.
Crossref
Crossref
Anant Pai, Maha M. El Shafei, Osman A.Z. Mohammed & Mustafa Al Hashimi. (2010) Current concepts in intravitreal drug therapy for diabetic retinopathy. Saudi Journal of Ophthalmology 24:4, pages 143-149.
Crossref
Crossref
Abha Gupta & Caroline Styles. (2010) An Overview of Diabetic Eye Disease. The British Journal of Diabetes & Vascular Disease 10:5, pages 224-230.
Crossref
Crossref
Dimithos Karagiannis, Vasileios Soumplis, Ilias Georgalas & Artemios Kandarakis. (2018) Ranibizumab for Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis: Favorable Results. European Journal of Ophthalmology 20:4, pages 792-794.
Crossref
Crossref
Benjamin P. Nicholson & Andrew P. Schachat. (2010) A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 248:7, pages 915-930.
Crossref
Crossref
M. Behnam- Rassouli, M.B. Ghayour & N. Ghayour. (2010) Microvascular Complications of Diabetes. Journal of Biological Sciences 10:5, pages 411-423.
Crossref
Crossref
Jacob M. Jones, Trevor McFarland & J. Timothy Stout. 2011. Therapeutic Angiogenesis for Vascular Diseases. Therapeutic Angiogenesis for Vascular Diseases
67
80
.